Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion

The role of the beta-adrenergic signaling pathway in heart failure (HF) is pivotal. Early blockade of this pathway with beta-blocker (BB) therapy is recommended as the first-line medication for patients with HF and reduced ejection fraction (HFrEF). Conversely, in patients with severe acute HF (AHF)...

Descripción completa

Detalles Bibliográficos
Autores principales: Schurtz, Guillaume, Mewton, Nathan, Lemesle, Gilles, Delmas, Clément, Levy, Bruno, Puymirat, Etienne, Aissaoui, Nadia, Bauer, Fabrice, Gerbaud, Edouard, Henry, Patrick, Bonello, Laurent, Bochaton, Thomas, Bonnefoy, Eric, Roubille, François, Lamblin, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693984/
https://www.ncbi.nlm.nih.gov/pubmed/38050613
http://dx.doi.org/10.3389/fcvm.2023.1263482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693984/
https://www.ncbi.nlm.nih.gov/pubmed/38050613
http://dx.doi.org/10.3389/fcvm.2023.1263482

Ejemplares similares